X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (85507) 85507
Newsletter (6644) 6644
Newspaper Article (5528) 5528
Book Chapter (430) 430
Magazine Article (181) 181
Dissertation (104) 104
Book / eBook (59) 59
Transcript (58) 58
Trade Publication Article (38) 38
Conference Proceeding (30) 30
Web Resource (29) 29
Reference (22) 22
Book Review (21) 21
Government Document (15) 15
Publication (9) 9
Report (2) 2
Streaming Video (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58241) 58241
hepatitis (28779) 28779
male (28321) 28321
female (27882) 27882
adult (20994) 20994
middle aged (20506) 20506
hepatitis c virus (19279) 19279
animals (16975) 16975
virology (15565) 15565
health aspects (15517) 15517
gastroenterology & hepatology (15064) 15064
hepacivirus - genetics (14365) 14365
hepatitis c (14358) 14358
infection (13293) 13293
genotype (13183) 13183
research (12660) 12660
viruses (12646) 12646
hepatitis b (11681) 11681
liver (11036) 11036
genetic aspects (10924) 10924
aged (10758) 10758
hepatitis b virus (10023) 10023
infections (9949) 9949
hepatitis b virus - genetics (9820) 9820
infectious diseases (9624) 9624
analysis (9218) 9218
interferon (9196) 9196
immunology (8550) 8550
antiviral agents - therapeutic use (8477) 8477
liver diseases (8179) 8179
risk factors (8173) 8173
virus diseases (8113) 8113
mice (7674) 7674
molecular sequence data (7588) 7588
proteins (7313) 7313
rna (6922) 6922
medical research (6772) 6772
research article (6733) 6733
medicine (6589) 6589
microbiology (6475) 6475
polymerase chain reaction (6428) 6428
mutation (6293) 6293
liver cancer (6258) 6258
prevalence (6145) 6145
expression (6054) 6054
hepatocellular carcinoma (5981) 5981
adolescent (5871) 5871
care and treatment (5816) 5816
multidisciplinary sciences (5779) 5779
treatment outcome (5767) 5767
base sequence (5759) 5759
gene expression (5650) 5650
hepatitis c, chronic - drug therapy (5505) 5505
hepatocellular-carcinoma (5455) 5455
cancer (5276) 5276
digestive system diseases (5269) 5269
oncology (5127) 5127
patients (5101) 5101
epidemiology (5054) 5054
biochemistry & molecular biology (5005) 5005
antiviral agents (4970) 4970
medicine, experimental (4947) 4947
hepatitis-c virus (4910) 4910
hepatitis c - virology (4894) 4894
disease (4794) 4794
dna (4780) 4780
therapy (4726) 4726
replication (4623) 4623
young adult (4618) 4618
cirrhosis (4564) 4564
science (4529) 4529
liver cirrhosis (4447) 4447
viral load (4382) 4382
antigens (4369) 4369
gastroenterology and hepatology (4349) 4349
rna, viral - blood (4228) 4228
liver - pathology (4136) 4136
hcv (4081) 4081
ribavirin (4079) 4079
studies (4075) 4075
interferon-alpha - therapeutic use (4039) 4039
hiv (4032) 4032
rna, viral - genetics (4022) 4022
cell line (3983) 3983
genotypes (3904) 3904
hepatitis c, chronic - virology (3884) 3884
hepatology (3874) 3874
hepacivirus - isolation & purification (3822) 3822
drug therapy, combination (3818) 3818
amino acid sequence (3781) 3781
genomes (3781) 3781
development and progression (3739) 3739
phylogeny (3648) 3648
diagnosis (3626) 3626
deoxyribonucleic acid--dna (3590) 3590
biological response modifiers (3568) 3568
antibodies (3506) 3506
genes (3446) 3446
medicine, research & experimental (3438) 3438
retrospective studies (3410) 3410
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Mt Sinai Hospital - Pathology (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (96786) 96786
Chinese (841) 841
Japanese (616) 616
French (519) 519
Portuguese (390) 390
Spanish (316) 316
Russian (233) 233
German (222) 222
Korean (85) 85
Turkish (74) 74
Polish (65) 65
Italian (53) 53
Hungarian (50) 50
Czech (17) 17
Norwegian (16) 16
Dutch (12) 12
Croatian (11) 11
Danish (10) 10
Romanian (8) 8
Arabic (7) 7
Persian (7) 7
Serbian (6) 6
Swedish (6) 6
Hebrew (5) 5
Slovak (3) 3
Ukrainian (3) 3
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2012, Volume 143, Issue 5, pp. 1244 - 1252.e12
Journal Article
Nature communications, ISSN 2041-1723, 2017, Volume 8, Issue 1, pp. 599 - 13
Infectious diseases have a profound impact on our health and many studies suggest that host genetics play a major role in the pathogenesis of most of... 
GENETIC-VARIATION | ALPHA-ENOLASE | JAPANESE POPULATION | MULTIDISCIPLINARY SCIENCES | HERPES-ZOSTER | DISEASE | INNER-EAR MORPHOGENESIS | MIDDLE-EAR | STEM-CELL ANTIGEN | EXPRESSION | SECRETOR STATUS | Tonsillitis - genetics | Otitis Media - surgery | Hepatitis B - genetics | Humans | Candidiasis, Vulvovaginal - genetics | Male | HLA Antigens - genetics | Rheumatic Fever - genetics | Tuberculin Test | Tuberculosis - diagnosis | Case-Control Studies | Pharyngitis - genetics | Streptococcal Infections - genetics | Hepatitis A - genetics | Sinusitis - genetics | Infections - genetics | Female | Otitis Media - genetics | Warts - genetics | Pneumonia - genetics | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Urinary Tract Infections - genetics | Mumps - genetics | Common Cold - genetics | Middle Ear Ventilation | Rubella - genetics | Scarlet Fever - genetics | Infectious Mononucleosis - genetics | Chickenpox - genetics | Tuberculosis - genetics | Meningitis, Bacterial - genetics | Tonsillectomy | Herpes Labialis - genetics | Herpes Zoster - genetics | Tonsillitis - surgery | Measles - genetics | Chronic Disease | Rubella | Yeast | Hepatitis A virus | Scarlet fever | Pathogenesis | Chronic infection | Amino acids | Mapping | Genomes | Infections | Urinary tract | Immunity | Hepatitis | Embryogenesis | Sinus | Mononucleosis | Measles | Varicella | Bacteria | Meningitis | Genetics | Mumps | Hepatitis B virus | Children | Rheumatic fever | Antigens | Health risks | Pharynx | Loci | Fever | Embryonic growth stage | Warts | Herpes labialis | Tuberculosis | Infectious diseases | Ear | Histocompatibility antigen HLA | Gene mapping | Hepatitis A | Hepatitis B
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 11/2013, Volume 19, Issue 41, pp. 6969 - 6978
... hepatitis C virus hepatitis, and possibly chronic hepatitis B virus hepatitis, hereditary hemochromatosis and primary sclerosing cholangitis... 
Liver disease | Patatin-like phospholipase domain-containing 3 | Chronic hepatitis C virus hepatitis | Genetics | Hepatocellular carcinoma | Nonalcoholic fatty liver disease | Single nucleotide polymorphism | Fibrogenesis | Alcoholic liver disease | Steatosis | CHRONIC HEPATITIS-C | NONALCOHOLIC STEATOHEPATITIS | GREATER-THAN-G | B-VIRUS INFECTION | HEPATOCELLULAR-CARCINOMA | INSULIN-RESISTANCE | FATTY LIVER | DOMAIN-CONTAINING 3 | GENETIC VARIANT | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Cholangitis, Sclerosing - enzymology | Hepatitis C, Chronic - pathology | Fatty Liver - pathology | Humans | Cholangitis, Sclerosing - genetics | Fatty Liver - complications | Hepatitis B, Chronic - enzymology | Hepatitis C, Chronic - complications | Liver Cirrhosis - enzymology | Hemochromatosis - pathology | Fatty Liver, Alcoholic - genetics | Hepatitis B, Chronic - genetics | Liver Cirrhosis, Alcoholic - enzymology | Hepatitis C, Chronic - enzymology | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Liver Neoplasms - pathology | Fatty Liver, Alcoholic - pathology | Liver Neoplasms - enzymology | Fatty Liver, Alcoholic - enzymology | Hepatitis B, Chronic - pathology | Liver Cirrhosis - genetics | Hemochromatosis - genetics | Fatty Liver - genetics | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Liver Cirrhosis, Alcoholic - pathology | Membrane Proteins - genetics | Risk Factors | Hemochromatosis - enzymology | Disease Progression | Polymorphism, Genetic | Cholangitis, Sclerosing - pathology | Fatty Liver, Alcoholic - complications | Liver Cirrhosis, Alcoholic - genetics | Phenotype | Liver Cirrhosis - pathology | Carcinoma, Hepatocellular | Hepatitis C, Chronic - genetics | Lipase - genetics | Review | Gastroenterologi | Hepatocellular | Gastroenterology and Hepatology
Journal Article
PLoS medicine, ISSN 1549-1676, 2011, Volume 8, Issue 9, p. e1001092
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 2, p. e17232
textabstractBackground: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome following interferon/ribavirin therapy in patients with chronic hepatitis C... 
GENETIC-VARIATION | IL28B | PLUS RIBAVIRIN | VIRUS-INFECTION | THERAPY | PEGINTERFERON ALPHA-2A | MULTIDISCIPLINARY SCIENCES | PROTEIN-10 | VIRAL RESPONSE | ASSOCIATION | Prognosis | Humans | Middle Aged | Polymorphism, Single Nucleotide - physiology | Male | Recombinant Proteins | Interleukins - analysis | Interleukins - metabolism | Interleukins - genetics | Chemokine CXCL10 - analysis | RNA, Viral - genetics | Adult | Female | Biomarkers, Pharmacological - analysis | Pharmacogenetics | Drug Administration Schedule | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Interferon-alpha - administration & dosage | Chemokine CXCL10 - genetics | Interferon alpha-2 | Hepatitis C, Chronic - genetics | Biomarkers, Pharmacological - metabolism | Chemokine CXCL10 - metabolism | Medical research | Care and treatment | RNA | Infection | Analysis | Medicine, Experimental | Genetic aspects | Interferon | Single nucleotide polymorphisms | Hepatitis C virus | Hepatitis C | Chromosomes | Health aspects | Therapy | Liver | Infections | Genomes | Single-nucleotide polymorphism | Ribonucleic acid--RNA | Patients | Ribavirin | Virology | Carriers | Hepatitis | Ethics | Infectious diseases | Hospitals | Correlation analysis | Gastroenterology | Predictions | IP-10 protein | Pretreatment | Genotypes | Pharmacological | Viral | Mikrobiologi inom det medicinska området | Single Nucleotide | genetics | administration & dosage | Interleukins | drug therapy | Interferon-alpha | physiology | diagnosis | Antiviral Agents | analysis | Chemokine CXCL10 | Chronic | Microbiology in the medical area | Biomarkers | metabolism | therapeutic use | Polymorphism | Ribonucleic acid
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy.... 
VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
Journal Article